Download PDF
1 / Pages

Other users also viewed these articles

Efficacy and safety of direct-acting antiviral agents for HCV in mild-to-moderate chronic kidney disease Ezequiel Ridruejo; Rebeca Garcia-Agudo; Manuel Mendizabal; Sami Aoufi-Rabih; Vivek Dixit; Marcelo Silva; Fabrizio Fabrizi;
Nefrologia (English Version). 2020;40:46-52
Comparison of efficacy and safety of the new generation helixone dialyzers Francisco Maduell; José Jesús Broseta; Diana Rodríguez-Espinosa; Lida María Rodas; Miquel Gómez; Marta Arias-Guillén; Néstor Fontseré; Manel Vera; Maria del Carmen Salgado; Nayra Rico; Rosa Ramos;
Nefrologia (English Version). 2024;44:354-61
Does uric acid-lowering treatment slow the progression of chronic kidney disease? A meta-analysis of randomized controlled trials Paulo Roberto Bignardi; Danielle Harumi Ido; Felipe Augusto Lopes Garcia; Lucas Mendes Braga; Vinicius Daher Alvares Delfino;
Nefrologia (English Version). 2023;43:167-81